Acromegaly and serum insulin-like growth factor I

Hormone Research

Volumn 62, Issue SUPPL. 1, 2004, Pages 34-36

  Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Acromegaly; Adults; Assays; Growth hormone; Insulin like growth factor

Indexed keywords

GROWTH HORMONE; PEGVISOMANT;

ACROMEGALY; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; IMMUNOASSAY; LABORATORY TEST; PRIORITY JOURNAL; VALIDATION PROCESS;

ACROMEGALY; ADULT; HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR I;

EID: 17244365393     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080756     Document Type: Conference Paper

References (13)

1. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
2. Hwa V, Oh Y, Rosenfeld R: The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999:20:761-787.
3. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein M, Kopchick J, LeRoith D: Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 2004;113:96-105.
4. Sjogren K, Liu J, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson O, Jansson J, Ohlsson C: Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 1999;96:7088-7092.
5. Barkan AL, Beitins IZ, Kelch RP: Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 1988;67:69-73.
6. Dimaraki E, Jaffe C: Troglitazone induces CYP3A4 activity leading to falsely abnormal dexamethasone suppression test. J Clin Endocrinol Metab 2003;88:3113-3116.
7. Clemmons D, Van Wyk J, Ridgway E, Kliman B, Kjellberg R, Underwood L: Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979;301:1138-1142.
8. Clemmons D: Commercial assays available for insulin-like growth factor I and their use in diagnosing growth hormone deficiency. Horm Res 2001;55(suppl 2):73-79.
9. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W. Ketelslegers JM. Wilhelmsen L. Hulthen L, Saller B. Mattsson A, Wilde J, Schemer R, Kann P: Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study. Horm Res 2003;60:53-60.
10. van der Lely AJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thonier MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ: Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 1999;342:1171-1177.
11. Clemmons DR, Chihara K, Freda PU, Ho KK, Klibanski A, Melmed S, Shalet SM, Strasburger CJ, Trainer PJ, Thorner MO: Optimizing control of acromegaly: Integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 2003:88:4759-4767.
12. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG: Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab 2001;86:3001-3008.
13. Freda P, Nuruzzaman A, Reyes C, Sundeen R, Post K: Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab 2004;89:495-500.